Lobbying client
NOSTRUM LABORATORIES
Generic Pharmaceutical Manufacturer
Filings
5
Filed by
1
Reported in-house
—
Reported by firms
$45,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2019 to 2020
Filings
5 filings, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
1st Quarter - Termination Amendment 1st Quarter 2020
|
PALLADIAN HILL STRATEGIES | — reported |
|
1st Quarter - Termination Amendmentreplaced 1st Quarter 2020
|
PALLADIAN HILL STRATEGIES | — reported |
|
4th Quarter - Amendment 4th Quarter 2019
|
PALLADIAN HILL STRATEGIES | $45,000 reported |
|
Registration - Amendment 4th Quarter 2019
|
PALLADIAN HILL STRATEGIES | — reported |
|
Registration 4th Quarter 2019
|
PALLADIAN HILL STRATEGIES | — reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| PALLADIAN HILL STRATEGIES | 2 | $45,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Health Issues | HCR | 3 |
| Government Issues | GOV | 1 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.